2020

Date:

29 Aug,2022

1 Month, Renamed as Wanbangde Pharmaceutical Group Co., Ltd.

2 Month, Wanbangde Successfully Completes Restructuring and Goes Public (Stock Code 002082 ), the pharmaceutical group enters the publicly listed company system

2021

2019

Related Recommendations

2025/04/14

Mingjie Pharma's inaugural national CMC pharmacy salon tour for 2025 concludes successfully | Wanbangde Pharmaceutical deeply engages in technical exchanges

2025/04/14

Good News | Maband Pharmaceutical Group's Mecobalamin Granted Orphan Drug Designation by the U.S. FDA for the Treatment of ALS

2025/04/14

[Another Milestone: Wanbangde Pharmaceutical Group's Huperzine A Injection Included in the "Clinical Guidelines for Rational Drug Use in Cerebrovascular Diseases"]

< 1 2 3 4...78 > proceed page

Home
About Us
- Company Profile
- HIstory
- Culture
- Honor
Products
R&D
- Academician Expert Workstation
- Medical Research and Industry Alliance
News
HR
- Talent Strategy
- Company recruitment
Contact us
中文版

Website Development: China Enterprise Dynamics Taizhou

Business license